(+)-Dinapsoline: An efficient synthesis and pharmacological profile of a novel dopamine agonist

Journal of Medicinal Chemistry

Volumn 45, Issue 17, 2002, Pages 3660-3668

  Sit, Sing Yuen ^a   Xie, Kai ^a   Jacutin Porte, Swanee ^a   Taber, Matthew T ^a   Gulwadi, Amit G ^a   Korpinen, Carolyn D ^a   Burris, Kevin D ^a   Molski, Thaddeus F ^a   Ryan, Elaine ^a   Xu, Cen ^a   Wong, Henry ^b   Zhu, Juliang ^b   Krishnananthan, Subramaniam ^b   Gao, Qi ^a   Verdoorn, Todd ^a   Johnson, Graham ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DINAPSOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; OXIDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYCLIZATION; DOPAMINE RECEPTOR BLOCKING; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; NONHUMAN; PARKINSON DISEASE; RAT; REACTION ANALYSIS; ROTATION; STRUCTURE ANALYSIS; X RAY ANALYSIS;

ANIMALS; CELL LINE; CORPUS STRIATUM; CRYSTALLOGRAPHY, X-RAY; CYCLIC AMP; DOPAMINE AGONISTS; ISOQUINOLINES; MOLECULAR CONFORMATION; NAPHTHOLS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STEREOISOMERISM;

EID: 0037103298     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0101545     Document Type: Article

References (31)

1. 1 agonist containing a rigid β-phenyldopamine pharmacophore
2. 1 dopamine receptor agonist in a rat model of Parkinson's disease
3. 1 agonist
4. 1 selective ligands
5. 1 dopamine agonist activity: Absolute configuration of β-methyldopamine
6. 1 receptor agonists A-86929 and ABT-431 in animal models of Parkinson's disease
7. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist
8. 1 receptor agonist with antiparkinsonian activity in marmosets
9. 1 dopamine receptor agonist
10. Dopamine agonists in the treatment of Parkinson's disease - Past, present and future
11. 1 receptors
12. 1 full agonist
13. Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3c]pyridine analog
14. 1 receptor agonists
15. 1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)
16. 1 dopamine receptor ligands
17. Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H-benzo[6,7] cyclohepta[1,2,3-ef][3]-benzazepine, 6,7-dihydroxy-1,2,3,4,8,12b-hexahydroanthr[10,-4a,4-cd]azepine, and 10-(aminomethyl)-9,10-dihydro-1,2-dihydroxy-anthracene as conformationally restricted analogs of β-phenyldopamine
18. 1 receptor agonist dihydrexidine in Parkinson's disease
19. 1 receptor agonist prodrug, has efficacy in Parkinson's disease
20. Ortho-directed lithiation of 3,4-(alkylenedioxy)-halobenzenes with LDA and LiTMP. The first ortho lithiation of an iodobenzene
21. The Swamping catalyst effect. VI. Halogenation of isoquinoline and quinoline
22. Synthesis and stereochemistry of some 8-substituted 2-methyldecahydroisoquinolines
23. 3 receptors in rat olfactory tubercle